Bacterial translocation during graft-versus-host disease after small bowel transplantation is reduced following inhibition of inducible nitric oxide synthesis.
Bacterial translocation during graft-versus-host disease after small bowel transplantation is reduced following inhibition of inducible nitric oxide synthesis.
复制标题
抑制诱导型一氧化氮合成后,小肠移植后移植物抗宿主病期间的细菌易位减少。
作者:
J. Langrehr;C. Machens;Edith Zill;K. Leder;Andreas N??ssler;Rosemary A. Hoffman;Peter Neuhaus
BACKGROUND
Increased nitric oxide (NO) production may contribute to intestinal barrier dysfunction and increased bacterial translocation (BT). Since BT may play a major role in graft-versus-host disease (GVHD) after small bowel transplantation (SBTx), we evaluated the role of NO production in GVHD after SBTX in the rat.
METHODS
Using the standard model of semiallogeneic SBTx in the rat, we prepared three experimental groups. Recipients in group 1 received LBNF1-LBNF1 transplants and were treated with aminoguanidine (AG) (200 mg/kg), recipients in group 2 received Lewis-LBNF1 grafts and were injected with saline, and recipients in group 3 received Lewis-LBNF1 transplants and AG (200 mg/kg). Urine nitrite/nitrate levels were measured daily, and BT was determined by culturing peritoneal swabs, mesenteric lymph nodes, spleen, liver, and blood.
RESULTS
In group 1 we detected indefinite survival with normal histology. In group 2 a survival of 10.5 +/- 1.1 days was reached, and the typical histological features of acute GVHD were observed. The animals in group 3 showed a mean survival of 14.8 +/- 0.6 days (P<0.02 compared with group 2) and the histological features of acute GVHD, although with a prolonged time course. Comparing NO production and BT between groups 2 and 3 we detected significantly reduced NO production on postoperative days 2-9 (P<0.03) and significantly decreased BT on postoperative days 3 and 9 (P<0.03).
CONCLUSION
Inhibition of inducible NO synthesis with AG reduces NO production, decreases BT, and prolongs survival during GVHD after SBTx and therefore may be a useful addition to standard treatment protocols for GVHD.
登录
查看更多内容
影响因子:
3.8
作者:
Langrehr,JM;Muller,AR;Bergonia,HA;Jacob,TD;Lee,TK;Schraut,WH;LancasterJr,JR;Hoffman,RA;Simmons,RL
通讯作者:
Simmons,RL
影响因子:
6.2
作者:
Worrall,NK;Boasquevisque,CH;Botney,MD;Misko,TP;Sullivan,PM;Ritter,JH;FergusonJr,TB;Patterson,GA
通讯作者:
Patterson,GA
DOI:
10.1152/ajpgi.1995.268.2.g361
发表时间:
1995-02-01
影响因子:
4.5
作者:
SALZMAN, AL;MENCONI, MJ;FINK, MP
通讯作者:
FINK, MP
影响因子:
29.4
作者:
Unno, N;Wang, HL;Fink, MP
通讯作者:
Fink, MP
影响因子:
6.2
作者:
Hoffman,RA;Langrehr,JM;Berry,LM;White,DA;Schattenfroh,NC;McCarthy,SA;Simmons,RL
通讯作者:
Simmons,RL